Stable circadian rhythms linked to better blood sugar control in type 2 diabetes

A team of researchers across South Korea's medical institutions has found something that reshapes how we think about managing type 2 diabetes: the stability of your daily rhythms matters as much as what you eat or how much you exercise. The work, led by Dr. Lee Da young and colleagues at Ansan Hospital, the Department of Psychiatry at Anam Hospital, and Sun Moon University's computer science division, tracked 122 insulin-treated diabetes patients over a decade-long study period from 2021 to 2024, equipping them with continuous glucose monitors and wearable activity trackers for ten consecutive days. What emerged from the data was striking: nearly half of the patients whose circadian rhythms were most stable—their sleep, activity, and heart rate patterns locked into consistent daily cycles—hit their blood glucose targets. That success rate was 46.3 percent. For patients whose daily rhythms were chaotic and irregular, the rate dropped to 20 percent. The difference was not marginal. It was 2.3 times higher.

The finding holds even when researchers account for the variables doctors already monitor closely: age, body mass index, and HbA1c levels, which measure average blood sugar over months. Circadian stability emerged as its own independent predictor of whether a patient could keep their glucose in the safe zone. The research, published in the journal Metabolism, suggests that the body's internal clock—the biological machinery that orchestrates sleep, wakefulness, hormone release, and metabolism across the twenty-four-hour cycle—is not incidental to diabetes control. It is central to it.

But the story gets more specific when you look at the timing of activity. The researchers divided the day into four windows: early morning from midnight to six, morning from six to noon, afternoon from noon to six, and evening from six to midnight. They then measured how many steps patients took during each period and correlated that with their glucose management. The strongest link appeared in the afternoon. Patients who moved more between noon and six in the evening showed better glucose control overall—they spent more time within their target range and experienced smaller swings in blood sugar levels. This was not true for activity at other times of day. The afternoon, it turned out, was when the body was most responsive to movement.

Sleep quality and duration also proved decisive. Patients who slept enough had a lower chance of experiencing hypoglycemia—dangerously low blood sugar—and their glucose levels fluctuated less wildly through the day. The body, when rested, seemed to regulate itself more smoothly. Dr. Lee Da young, the lead researcher, framed the implication plainly: diabetes care has long centered on three pillars—diet, exercise, and medication. The new evidence suggests a fourth pillar has been overlooked. "Maintaining regular and stable lifestyle rhythms can help manage your blood glucose levels," she said. The conventional approach has been to tell patients what to eat and when to move. This research indicates that how consistently they do those things—the rhythm and regularity of their days—may matter just as much as the actions themselves.

The team is not stopping here. They plan to move from observation to intervention. The next phase will test whether actively helping patients restructure their daily patterns—adjusting sleep schedules, timing activity, stabilizing routines—actually improves their blood glucose control in real time. They also intend to explore whether circadian stability affects not just glucose management but the serious long-term complications of diabetes: kidney disease and vision loss. For now, the message is clear: the clock inside your body is not background noise. For people managing type 2 diabetes, it may be one of the most important tools they have.